disease management
programmes
A guide for managers and supervisors
in the oil and gas industry
Health
2012
The global oil and gas industry association for environmental and social issues
5th Floor, 209215 Blackfriars Road, London SE1 8NL, United Kingdom
Telephone: +44 (0)20 7633 2388 Facsimile: +44 (0)20 7633 2389
E-mail: info@ipieca.org Internet: www.ipieca.org
No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any
form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the
prior consent of IPIECA.
This publication is printed on paper manufactured from fibre obtained from sustainably grown
softwood forests and bleached without any damage to the environment.
Vector-borne
disease management
programmes
A guide for managers and supervisors
in the oil and gas industry
All photographs are reproduced courtesy of Shutterstock.com except: page 2: Wikimedia Commons
US Centers for Disease Control and Prevention; page 3 (inset): Wikimedia CommonsUS Centers for Disease
Control and Prevention/Dr Myron G. Schultz; page 4: BP; page 6: Asianet-Pakistan/Shutterstock.com;
page 7: Mauro/Shutterstock.com; Page 11: Frontpage/Shutterstock.com; and page 28: Thiery Heger
(licensed under a Creative Commons Generic Licence).
IPIECA
OGP
Contents
Purpose of this guide
Introduction
Vector-borne diseases
Definitions
13
13
13
13
Secondary management
15
Education
15
Avoidance
15
16
Repellants
16
Room precautions
17
Immunization
17
Chemoprophylaxis
17
18
Returning travellers
19
19
Standby treatment
20
Screening
Appendix 1:
Understanding the need for
chemoprophylaxis
21
Scoping
Appendix 2:
Some specific vector-borne diseases
23
Malaria
23
Stakeholder consultation
Yellow fever
24
Risk assessment
10
Dengue
25
Decision making
11
Japanese encephalitis
26
Mitigation
11
27
11
29
Implementation
11
Monitoring
12
Tick-borne encephalitis
30
Rickettsial infections
31
Leishmaniasis
32
Appendix 3:
Neglected tropical diseases
33
Glossary
34
37
Evaluation
ii
12
The importance of
vector-borne
operations should
not be
underestimated.
programmes (VBDMPs).
www.iogp.org/pubs/382/Appendix_B.pdf
www.iogp.org/pubs/382/Appendix_D.xls
Introduction
The oil and gas industry is committed to
IPIECA
OGP
Vector-borne diseases
Definitions
www.cdc.gov/ncezid/dvbd/about.html
gas industry.
Sand fly
Leishmaniasis
Black fly
Tse-tse fly
Triatomine bugs
Soft ticks
Hard ticks
Fleas
Lice
Mites
Disease
Scrub typhus
Annual deaths
39 million
243
800,000
18-842,000
0.2
30,000
700,000
50
19,000
107-755,000
0.05
10,000
Leishmaniasis
2.1 million
12
51,000
Human African
trypanosomiasis
(HAT)
1.5 million
<0.1
48,000
Chagas disease
700,000
8-9
15,000
Malaria
Yellow fever
Dengue
Japanese
encephalitis
Modified from Hotez et al. with additions from the World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC).
of the parasite
Trypanosoma cruzi,
which is transmitted
to animals and
people by vectors,
and is a recognized
cause of Chagas
diseasean illness
750,000 working
due to premature
deaths in South
America.
IPIECA
OGP
North America.
effective way.
Use of fogging at
sunset to control
dengue: many
vector-borne
diseases demonstrate
remarkable
resilience in human
populations despite
enormous efforts to
eradicate it.
IPIECA
OGP
Consultation
is also important.
between
international
stakeholders is vital
in the prevention,
management and
control of VBDrelated issues.
IPIECA
OGP
Screening
impact assessments.
business activity.
Scoping
Scoping is a term that is generally used to describe
Mitigation strategydevelop a written mitigation action plan (vectorborne disease management programme).
For
Stakeholder consultation
IPIECA
OGP
Risk assessment
companies have
internal risk
environmental,
aspects of proposed
new activities.
assessment
procedures and
protocols covering
the health,
Decision making
Decision making establishes priorities and begins
the process of developing and dedicating
appropriate resources. For episodic or small-scale
business activities the implementation of existing
standard practices (e.g. a VBD visa programme)
may be entirely sufficient. For large, long-term
operations, many companies have established
No single VBDMP
can be guaranteed
to be completely
Implementation
effective, and in
some situations, the
may be necessary.
treatment or
evacuation of
Mitigation
IPIECA
OGP
Monitoring
incident investigations.
jungles, etc.);
to medication.
A suggested audit form for a malaria management
Evaluation
Small pools of
standing water
as Anopheles,
Aedes, prefer
stagnant water in
containers, such as
authorities.
expensive option.
13
IPIECA
OGP
Residual spraying
This refers to the process of applying insecticide to
the interior walls of living and working quarters in
order to leave a long-term residue of insecticide that
kills adult insects over a prolonged period. A typical
residual spraying schedule might be as infrequently
as six-monthly to yearly. Although there have been
some concerns over the persistent exposure of
pregnant women and nursing mothers to insecticide
residue, the practice appears to be generally safe
and can be very effective. The primary issue is the
choice of insecticide, with regard to insect resistance,
possible effects on humans and the cost or availability
of alternatives. A prolonged debate has taken place
regarding the use of dichlorodiphenyltrichloroethane
(DDT) and alternatives, involving environmental,
health, resistance and other issues. Although
cheap, safer alternatives may be available, it has
been recognized by the WHO that the use of DDT
for residual spraying may still be the most
appropriate method in some situations.
Access
Important, but simple, control can be achieved by
preventing access of vectors to dwellings and
offices, e.g. through the use of well fitting doors
and windows. Door and window screens are
effective, but must be maintained with no holes or
gaps at the edges.
Search and destroy
Active searching for mosquitoes that have eluded
other controls, and killing them with a knock
down spray is useful. Searches should be actively
carried out for insects inside cupboards, in
curtains, in lampshades, and even within the folds
of mosquito nets!
Avoidance
Local insect vectors should be avoided. Young
children may be kept indoors from early dusk
onwards to avoid night-flying insects, but they will
Ground clearance
Local ground clearance to eliminate breeding or
resting sites of insects around compounds, camps
or other buildings may be appropriate. Ticks may
thrive in scrub and grass, while rodents may be
hosts for the diseases of concern.
Secondary management
Education
are understood.
IPIECA
OGP
manufacturers recommendations.
Repellents
The ideal personal insect repellent should be
can be effective.
include:
apply as directed;
treated areas;
16
Duration of action
20%
13 hours
30%
Up to 6 hours
50%
Up to 12 hours
Chemoprophylaxis
Malaria is one of very few conditions in which
preventive drugs are routinely given as a
prophylactic. Excellent advice is now available on
chemoprophylaxis for malaria from a variety of
national and international sources. When
considering this topic, it is important that up-to-date
and destination-specific guidance is obtained and
followed. A doctor should be consulted to evaluate
its use and restrictions, and to give specific
recommendations.
In principle, a number of issues need to be
addressed:
Room precautions
Mosquitoes may get into all sorts of unlikely
locations, including cars and aeroplanes. Rooms or
apartments may be air-conditioned, but this does
not make it inaccessible or inhospitable to
mosquitoes. The following precautions are
year round?
Is chemoprophylaxis indicated?
conditions, be managed?
room corners.
Consider using chemical mosquito mats or liquid
in a vaporizer overnight; burning mosquito coils
be used.
recommended:
Immunization
IPIECA
OGP
unavoidable.
unstable malaria.
18
Returning travellers
take the drug for the rest of his or her life. One
by chemoprophylaxis.
evening or morning.
IPIECA
OGP
Standby treatment
life?
These include:
followed precisely;
disadvantages; and
minimal training.
20
Appendix 1:
Understanding the need for chemoprophylaxis
Failure to appreciate the need for
Failure to appreciate
chemoprophylaxis is a
common problem:
assignees must be
is a serious and
debilitating illness, if
take reasonable
they say;
precautions to avoid
working.
management.
21
IPIECA
OGP
22
Appendix 2:
Some specific vector-borne diseases
The Anopheles
Malaria
mosquito plays a
prominent role in
the transmission of
malaria to humans.
90% involve children under 5 years old in subSaharan Africa. The social and economic losses
each year due to death from malaria and the
debility caused by repeat infections is huge in
regions of the world that are least able to withstand
it. The initial manifestation is usually a severe flu-
Causative agent
Incubation period
The incubation period varies according to the type
of parasite. In general, this period is around 10
Diagnosis
community.
IPIECA
OGP
Distribution
Differential diagnosis
http://gamapserver.who.int/mapLibrary/Files/
Maps/Global_Malaria_ReportedCases_2010.png
Yellow fever
Treatment
virus-specific antibodies.
Infective agent
Yellow fever is caused by an RNA virus of the
24
years.
encephalitis.
Prevention
Vector
Prevention
Dengue
Distribution
IPIECA
OGP
Prevention
Infective agent
Vector
Japanese encephalitis
Distribution
26
Japanese
encephalitis is most
commonly spread
by the Culex genus
of mosquito.
Causative agent
The disease is caused by an RNA virus of the
flavivirus group.
disease are used as a routine childhood vaccine.
American trypanosomiasis
(Chagas disease)
cannot be excluded.
Most patients recover from the acute phase, but
Prevention
IPIECA
OGP
Diagnosis
Vector
The parasite is spread through contact with the
faeces of triatomine bugs. A number of species are
Treatment
Causative organism
Rhodnius prolixus is
an important
triatomine vector of
the Chagas
parasite due to its
efficient adaptation
to the human
domicile in northern
South America.
28
Distribution
Diagnosis
Acute phase T.b. gambiense may be diagnosed by
Prevention
for screening.
Treatment
highly specialized.
Causative organism
HAT is caused by two subspecies of the parasite
IPIECA
OGP
Vector
ratio of 3%.
Distribution
patients.
Causative organism
The disease is caused by an RNA flavivirus.
Prevention
Tick-borne encephalitis
Tick-borne encephalitis (TBE) may present as a
30
Prevention
Relevance
Rickettsial infections
Prevention
Disease
Agent
Vector
Distribution
Rickettsia rickettsiae
tick
North America
Rickettsia coroni
tick
Rickettsia africae
tick
Sub-Saharan Africa
Orientia* tsutsugamushi
mite larva
Far East
Rickettsia prowazekii
louse
Rickettsia typhi
flea
Scrub typhus
Epidemic typhus
Murine (endemic) typhus
31
IPIECA
OGP
Vector
murine typhus.
Leishmaniasis
Distribution
Cutaneous leishmaniasis
This is characterized by the development of
Prevention
more destructive.
Visceral leishmaniasis
32
Appendix 3:
Neglected tropical diseases
Often neglected is a group of disabling, and
and money.
is still significant.
Transmission
Chagas *
Dengue *
Rabies
Animal bite
Trachoma
Buruli ulcer
Leprosy
HAT *
Dracunculiasis
Lymphatic filariasis
Onchocerciasis
Schistosomiasis
Soil-transmitted
Endemic treponematoses
Cysticercosis
Echinococcosis
Leishmaniasis *
Fascioliasis
33
IPIECA
OGP
Glossary
ABCD: a simple way to remember the key steps
needed to protect people from malaria: Awareness,
Bite prevention, Chemoprophylaxis, Diagnosis.
IPIECA
OGP
Information for International Travel. In addition, the CDCs Division of Vector-Borne Diseases (DVBD)
provides information on a range of vector-borne diseases: the DVBDs information pamphlet can be
downloaded from: www.cdc.gov/ncezid/dvbd/pdf/dvbd-pamphlet-2011.pdf
European Centre for Disease Control: collects, coordinates and disseminates information on infectious
disease in Europe or that may impact Europe. Publishes a newsletter and updates.
www.ecdc.europa.eu/en/healthtopics
Health Protection Agency: UK agency responsible for general health advice and guidance. Incorporates the
Malaria Reference Laboratory. www.hpa.org.uk
NaTHNaC: National Travel Health Network and Centre. Main UK body for advice on travel health in the
UK. Provides extensive information online, and publishes the UK Yellow Book, Health Information for
Overseas Travel: Prevention of Illness in Travellers from the UK. It administers the yellow fever vaccination
programme for the UK. www.nathnac.org
International Society for Infectious Diseases: produces the internet service ProMed-mail which provides
regular and frequent mails on disease outbreaks worldwide, including animal and plant diseases.
www.promedmail.org
37
IPIECA is the global oil and gas industry association for environmental and social issues. It develops,
shares and promotes good practices and knowledge to help the industry improve its environmental and
social performance, and is the industrys principal channel of communication with the United Nations.
Through its member-led working groups and executive leadership, IPIECA brings together the collective
expertise of oil and gas companies and associations. Its unique position within the industry enables its
members to respond effectively to key environmental and social issues.
5th Floor, 209215 Blackfriars Road, London SE1 8NL, United Kingdom
Telephone: +44 (0)20 7633 2388 Facsimile: +44 (0)20 7633 2389
E-mail: info@ipieca.org Internet: www.ipieca.org
OGP represents the upstream oil and gas industry before international organizations including the
International Maritime Organization, the United Nations Environment Programme (UNEP) Regional
Seas Conventions and other groups under the UN umbrella. At the regional level, OGP is the industry
representative to the European Commission and Parliament and the OSPAR Commission for the North
East Atlantic. Equally important is OGPs role in promulgating best practices, particularly in the areas
of health, safety, the environment and social responsibility.
London office
5th Floor, 209215 Blackfriars Road, London SE1 8NL, United Kingdom
Telephone: +44 (0)20 7633 0272 Facsimile: +44 (0)20 7633 2350
E-mail: reception@ogp.org.uk Internet: www.ogp.org.uk
Brussels office
Boulevard du Souverain 165, 4th Floor, B-1160 Brussels, Belgium
Telephone: +32 (0)2 566 9150 Facsimile: +32 (0)2 566 9159
E-mail: reception@ogp.org.uk Internet: www.ogp.org.uk